The transformation of FL into DLBCL occurs in approximately 30% of patients, but transformation into B-ALL is rare, with most cases characterized an MYC rearrangement in addition to an IGH/BCL2 fusion [2, 8–15]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.